Bill Would Require Extensive Pricing Disclosures From Drug Companies

Bill Would Require Extensive Pricing Disclosures From Drug Companies

State Sen. Ed Hernandez, D-West Covina, has introduced legislation that would compel a significant level of price transparency and cost disclosures on the part of drug manufacturers. The bill has gained the support of California's health insurers despite extensive reporting burdens placed on them as well.

Hernandez has been a highly vocal critic of the recent business practices of drug manufacturers, which include huge increases for the prices of medications that have often been on the market for decades.

Full text of California Payers and Providers articles is available to premium subscribers only. Subscribe to receive the weekly California Payers and Providers newsletter and get access to the archive of all of the newsletter articles.